Artificial intelligence (AI) and socioeconomic factors enhance risk stratification for patients with acute myeloid leukemia (AML) post transplant, aiming to reduce hospital readmissions and disease ...

Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation ...